Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model

Medical Science Monitor

Volumn 18, Issue 11, 2012, Pages

  Calik, Sebnem ^a   Turhan, Tuncer ^b   Yurtseven, Taskin ^b   Sipahi, Oguz Resat ^b   Buke, Cagri ^b  

^a Department of Infectious Diseases and Clinical Microbiology   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Linezolid; Meningitis; Methicillin resistant Staphylococcus aureus; MRSA; Rabbits

Indexed keywords

LINEZOLID; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL MENINGITIS; COLONY FORMING UNIT; CONTROLLED STUDY; EXPERIMENTAL RABBIT; INCUBATION TIME; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS MENINGITIS; MORTALITY; NONHUMAN;

EID: 84868563483     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/msm.883528     Document Type: Article

References (19)

1. Arda B, Yamazhan T, Sipahi OR et al: Meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): review of 10 cases. Int J Antimicrob Agents, 2005; 25(5): 414-18
2. Sipahi OR, Bardak S, Turhan et al: Linezolid in the treatment of methicillin-resistant staphylococcal post-neurosurgical meningitis: a series of 17 cases. Scand J Infect Dis. 2011; 43(10): 757-64
3. Rupprecht TA, Pfister HW: Clinical experience with linezolid for the treatment of central nervous system infections. Eur J Neurol, 2005; 12: 536-42
4. Lee DH, Palermo B, Chowdhury M: Successful treatment of methicillinresistant Staphylococcus aureus meningitis with daptomycin. Clin Infect Dis, 2008; 47(4): 588-90
5. Kessler AT, Kourtis AP: Treatment of meningitis caused by methicillinresistant Staphylococcus aureus with linezolid. Infection, 2007; 35: 271-74
6. Ntziora F, Falagas ME: Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother, 2007; 41: 296-308
7. Kunst H, Paruchuru PK, Madden B: Bacterial endocarditis: a rare complication following orthotopic cardiac transplantation. J Heart Lung Transplant, 2001; 20: 483-85
8. Bilgehan H: Klinik Mikrobiyolojik Tani{dotless}. 3. edition, Fakülteler Bari{dotless}s Yayi{dotless}nlari{dotless}
9. Suntur BM, Yurtseven T, Sipahi OR et al: Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin-and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model. Int J Antimicrob Agents, 2005; 26: 258-60
10. Sipahi OR, Arda B, Yurtseven T et al: Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis. Int J Antimicrob Agents, 2005; 26: 412-15
11. Cottagnoud P, Gerber CM, Acosta F et al: Linezolid against penicillinsensitive and-resistant pneumococci in the rabbit meningitis model. J Antimicrob Chemother, 2000; 46: 981-85
12. Jacqueline C, Caillon J, Le Mabecque V et al: In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model. Antimicrob Agents Chemother, 2007; 51(9): 3397-400
13. Lee H, Song JH, Kim SW et al: Evaluation of a triple-drug combination for treatment of experimental multidrug-resistant pneumococcal meningitis. Int J Antimicrob Agents, 2004; 23(3): 307-10
14. Chaudhuri AP, Martin PM, Kennedy PGE et al: EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol, 2008; 15(7): 649-59
15. Myrianthefs P, Markantonis SL, Vlachos K et al: Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients. Antimicrob Agents Chemother, 2006; 50: 3971-76
16. Usluer G: Linezolid. Ankem Dergisi 2010; 4(Suppl.2): 114-18
17. Villani P, Regazzi MB, Marubbi F et al: Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections. Antimicrob Agents Chemother, 2002; 46: 936-37
18. Grohs P, Kitzis MD, Gutmann L: In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus. Antimicrob Agents Chemother, 2003; 47: 418-20
19. Sahuquillo Arce JM, Colombo Gainza E, Gil Brusola A et al: In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus. Rev Esp Quimioter, 2006; 19: 252-57